Amit Kumar
Weill Medical College of Cornell University, USA
Editorial board member profile and journal affiliation.
Weill Medical College of Cornell University, USA
<div>
Dr. Kumar’s research focusses on identifying therapeutic targets and thereby, helping patients of Alzheimer’s disease, Huntington’s disease, Traumatic Brain Injury, Stroke and other congenital diseases with appropriate therapy. He is currently involved in examining defects in glucose metabolism occurring at very early pre-symptomatic stages of Alzheimer’s disease and Huntington’s disease.</div>
<div>
<div id="cke_pastebin" style="position: absolute; left: -1000px; top: 8px; width: 1px; height: 1px; overflow: hidden;">
Dr. Kumar’s research focusses on identifying therapeutic targets and thereby, helping patients of Alzheimer’s disease, Huntington’s disease, Traumatic Brain Injury, Stroke and other congenital diseases with appropriate therapy. He is currently involved in examining defects in glucose metabolism occurring at very early pre-symptomatic stages of Alzheimer’s disease and Huntington’s disease.</div>
<div>
<div id="cke_pastebin" style="position: absolute; left: -1000px; top: 8px; width: 1px; height: 1px; overflow: hidden;">
Dr. Kumar’s research focusses on identifying therapeutic targets and thereby, helping patients of Alzheimer’s disease, Huntington’s disease, Traumatic Brain Injury, Stroke and other congenital diseases with appropriate therapy. He is currently involved in examining defects in glucose metabolism occurring at very early pre-symptomatic stages of Alzheimer’s disease and Huntington’s disease.</div>
<div>
<div id="cke_pastebin" style="position: absolute; left: -1000px; top: 8px; width: 1px; height: 1px; overflow: hidden;">
Dr. Kumar’s research focusses on identifying therapeutic targets and thereby, helping patients of Alzheimer’s disease, Huntington’s disease, Traumatic Brain Injury, Stroke and other congenital diseases with appropriate therapy. He is currently involved in examining defects in glucose metabolism occurring at very early pre-symptomatic stages of Alzheimer’s disease and Huntington’s disease.</div>
<div>
</div>
</div>
</div>
</div>